These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20657078)

  • 21. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
    Schoening TE; Wagner J; Arvand M
    Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes.
    Pires R; Rolo D; Mato R; Feio de Almeida J; Johansson C; Henriques-Normark B; Morais A; Brito-Avô A; Gonçalo-Marques J; Santos-Sanches I
    FEMS Microbiol Lett; 2009 Jun; 296(2):235-40. PubMed ID: 19486163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
    Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
    J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
    Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus.
    Porter MC; Henderson BA; Healy PE; Coombs GW; Ingram PR; McLellan D; Clark B
    J Antimicrob Chemother; 2014 Mar; 69(3):856-7. PubMed ID: 24164721
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased expression of the ska gene in emm49-genotyped Streptococcus pyogenes strains isolated from patients with severe invasive streptococcal infections.
    Ikebe T; Endoh M; Watanabe H
    Jpn J Infect Dis; 2005 Oct; 58(5):272-5. PubMed ID: 16249619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
    Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
    J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.
    Imöhl M; van der Linden M
    PLoS One; 2015; 10(9):e0137313. PubMed ID: 26340445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae.
    Culebras E; Rodríguez-Avial I; Betriu C; Picazo JJ
    J Antimicrob Chemother; 2005 Nov; 56(5):836-40. PubMed ID: 16186169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.
    Silva-Costa C; Pinto FR; Ramirez M; Melo-Cristino J;
    Clin Microbiol Infect; 2008 Dec; 14(12):1152-9. PubMed ID: 19046174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes.
    Sawai J; Hasegawa T; Kamimura T; Okamoto A; Ohmori D; Nosaka N; Yamada K; Torii K; Ohta M
    Antimicrob Agents Chemother; 2007 Feb; 51(2):461-7. PubMed ID: 17101685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rifampin resistance in Streptococcus pyogenes.
    Herrera L; Salcedo C; Orden B; Herranz B; Martinez R; Efstratiou A; Sáez Nieto JA
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):411-3. PubMed ID: 12072931
    [No Abstract]   [Full Text] [Related]  

  • 34. Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus.
    Koliou M; Ioannou Y; Efstratiou A; Hannidou N; Pieri V; Alexandrou M; Soteriades ES
    Clin Microbiol Infect; 2007 Jun; 13(6):645-7. PubMed ID: 17378928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland.
    Sadowy E; Matynia B; Hryniewicz W
    J Antimicrob Chemother; 2010 Sep; 65(9):1907-14. PubMed ID: 20584746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area.
    Ferraro AL; Mortensen JE; Blecker DL; Phengvath C
    Adv Exp Med Biol; 1995; 390():119-21. PubMed ID: 8718607
    [No Abstract]   [Full Text] [Related]  

  • 37. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
    Orscheln RC; Johnson DR; Olson SM; Presti RM; Martin JM; Kaplan EL; Storch GA
    J Infect Dis; 2005 Apr; 191(8):1272-9. PubMed ID: 15776373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain.
    Alonso R; Mateo E; Ezpeleta G; Cisterna R
    Int J Antimicrob Agents; 2007 Aug; 30(2):183-5. PubMed ID: 17543504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates.
    Rombini S; Petrelli D; Bolli E; Tran CN; Falconi M; Di Luca MC; Prenna M; Ripa S; Vitali LA
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):387-94. PubMed ID: 21683270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.